APA (7th ed.) Citation

Digomann, D., Reiche, C., Stammberger, A., Willms, T., Rudek, L., Grabenkamp, A., . . . Seifert, A. (2025). 2176P Serum levels of galectin-9 predict the survival of patients with gastric and gastroesophageal junction adenocarcinoma. Annals of Oncology, 36, S1217. https://doi.org/10.1016/j.annonc.2025.08.2795

Chicago Style (17th ed.) Citation

Digomann, D., et al. "2176P Serum Levels of Galectin-9 Predict the Survival of Patients with Gastric and Gastroesophageal Junction Adenocarcinoma." Annals of Oncology 36 (2025): S1217. https://doi.org/10.1016/j.annonc.2025.08.2795.

MLA (9th ed.) Citation

Digomann, D., et al. "2176P Serum Levels of Galectin-9 Predict the Survival of Patients with Gastric and Gastroesophageal Junction Adenocarcinoma." Annals of Oncology, vol. 36, 2025, p. S1217, https://doi.org/10.1016/j.annonc.2025.08.2795.